ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism

Clinical trial NCT02806817 · COMPLETED

Trial details

NCT number: NCT02806817
Sponsor: Centro Nacional de Investigaciones Oncologicas CARLOS III
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Early-Stage Breast Carcinoma

Start date: 2016-07-01
Primary completion: 2018-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.